Longitudinal Study of Comorbidities and Clinical Outcomes in Persons With Pancreatic Disease Using Electronic Health Records [0.03%]
基于电子健康档案的胰腺病患者合并症及临床转归的纵向研究
Aynur Unalp-Arida,Jane S Der,Constance E Ruhl
Aynur Unalp-Arida
Objectives: We examined comorbidities and clinical outcomes among persons with pancreatic disease using electronic health records (EHR). Methods: ...
Clinical Outcomes of Ablative MR-Guided Adaptive SBRT for Pancreatic Lesions [0.03%]
磁共振引导自适应立体定向体部放射治疗胰腺病变的临床疗效分析
James J Sohn,Yirong Liu,Sara Lim et al.
James J Sohn et al.
Purpose: To assess the efficacy, safety and treatment‑course dynamics of ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy (SMART) for unresectable pancreatic lesions. ...
Isolated Exocrine Pancreatic Insufficiency During Pembrolizumab Therapy: Extending the Spectrum of ICI‑Induced Pancreatic Injury [0.03%]
派姆单抗治疗期间出现孤立性胰腺外分泌功能不全：扩展ICI所致胰腺损伤的类型
Blake H Bentley,Kshitij Thakur
Blake H Bentley
Zejun Song
Zejun Song
Effect of Skeletal Muscle Mass Loss on Outcomes of Patients With Intraductal Papillary Mucinous Neoplasm [0.03%]
肌肉消耗对胰腺导管内乳头状黏液性肿瘤患者预后的影响分析
Soichiro Oda,Kazumichi Kawakubo,Ryo Takagi et al.
Soichiro Oda et al.
Objective: To investigate the association between skeletal muscle mass loss and long-term outcomes in patients with intraductal papillary mucinous neoplasm (IPMN). ...
Knockdown of Lymphoid Enhancer-binding Factor 1 Inhibits Pancreatic Adenocarcinoma Growth and Neoangiogenesis by Curbing Notch1 and Nuclear Factor Kappa B Signaling Pathways [0.03%]
淋巴增强因子1基因敲低通过抑制诺特定点1和核因子κB信号通路抑制胰腺癌生长和新生血管生成
Guanglun Ping,Guoyong Cai,Ying Wei et al.
Guanglun Ping et al.
Objectives: To investigate the impaction of LEF1 for malignant development of pancreatic adenocarcinoma (PAAD) and its specific mechanisms. Materials and ...
The Transcription Factor TFAP2A Induces M2 Macrophage Polarization by Upregulating EPS8L3 Expression, Thereby Accelerating the Malignant Progression of Pancreatic Ductal Adenocarcinoma [0.03%]
转录因子TFAP2A通过上调EPS8L3表达诱导M2型巨噬细胞极化从而加速胰腺导管腺癌恶性进展
Yilihamu Maimaiti,Zaiyinuer Abuduwaili,Dong Yan et al.
Yilihamu Maimaiti et al.
Background: Pancreatic ductal adenocarcinoma (PDAC), the main pancreatic cancer type, was highly aggressive and lethal. Studies showed that the epidermal growth factor receptor pathway substrate 8-Like protein 3 (EPS8L3) ...
The Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC) 10 years of Past Accomplishments and Looking Forward to the Next 5 Years of the Chronic Pancreatitis Clinical Research Consortium (CPCRC) [0.03%]
慢性胰腺炎、糖尿病和胰腺癌研究联盟（CPDPC）：过去的成就及面向未来的五年计划——慢性胰腺炎临床研究联盟(CPCRC)
Chris E Forsmark,Stephen Pandol
Chris E Forsmark
This article provides an overview of 10 years of accomplishments of the National Institute of Diabetes and Digestive and Kidney Diseases supported Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC); an...
Clinical Characteristics of Acute and Chronic Pancreatitis in Children and Impact of Obesity [0.03%]
儿童急性胰腺炎和慢性胰腺炎的临床特点及肥胖的影响
Yanxia Chen,Jinlin Liu
Yanxia Chen
Xiaotian Feng,Jiyan Lin
Xiaotian Feng
Background: Acute pancreatitis (AP) is a prevalent gastrointestinal emergency with a substantial risk of severe complications. Evidence indicates that glucocorticoids (GCs) may attenuate organ failure and reduce mortality...